Brief: Cipher Pharmaceuticals Reports First Quarter 2022 Results
12/05/2022 22:20
May 12 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS REPORTS STRONG FIRST QUARTER 2022
FINANCIAL RESULTS
* CIPHER PHARMACEUTICALS INC - QTRLY EARNINGS PER SHARE
$0.08
* CIPHER PHARMACEUTICALS INC - QTRLY ADJUSTED EBITDA PER
SHARE
DILUTIVE $0.12
Source text for Eikon: ID:nCNWqxbHsa
Further company coverage: CPH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million